Voglicad 0.2mg Tablet
Marketer
Cadomed Pharmaceuticals Pvt Ltd
Salt Composition
Voglibose (0.2mg)
Overview Voglicad 0.2mg Tablet
DiaBeta 0.2mg tablets are prescribed for managing type 2 diabetes. This medication assists in regulating elevated post-prandial blood glucose. It's indicated when dietary modifications and other comparable treatments prove insufficient in controlling hyperglycemia. DiaBeta 0.2mg should be administered immediately prior to meals. Dosage frequency is determined by your physician to optimize glycemic control. Discontinue use only under medical supervision; abrupt cessation can elevate blood sugar, potentially causing severe complications like renal impairment and vision loss. This medication is a component of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is crucial. Common side effects include bloating, abdominal discomfort, anorexia, constipation, and diarrhea. Report persistent or troublesome side effects to your physician. While DiaBeta 0.2mg alone doesn't induce hypoglycemia, concurrent use with other antidiabetic agents (particularly insulin or sulfonylureas) may. Glucose tablets are necessary to treat such episodes; table sugar is ineffective. Inform your doctor of any kidney or liver conditions before commencing treatment. This medication is contraindicated in individuals with bowel inflammation or ulceration (e.g., ulcerative colitis, Crohn's disease). Pregnant or lactating individuals must consult their physician prior to use. Always disclose all medications to your doctor to ensure medication safety. Limit alcohol consumption while taking this medication to minimize hypoglycemia risk.
Uses of Voglicad 0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Voglicad 0.2mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Voglicad 0.2mg Tablets should be taken on an empty stomach.
Common Side effects of Voglicad 0.2mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglicad 0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer Voglicad 0.2mg Tablet on an empty stomach.
How Voglicad 0.2mg Tablet works:
Voglicad 0.2mg tablets are used to manage diabetes. Their mechanism of action involves blocking the enzymes in the intestines that digest complex carbohydrates into easily absorbed glucose. This action helps to moderate postprandial blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglicad 0.2mg Tablet with alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
Use of Voglicad 0.2mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; clinical data in humans, however, remains scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Voglicad 0.2mg tablets while breastfeeding appears to pose minimal risk. Available data from human studies indicate negligible danger to the infant.
DrivingSAFE
Driving ability is typically unaffected by Voglicad 0.2mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Voglicad 0.2mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Voglicad 0.2mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Voglicad 0.2mg Tablet :
Omit any missed Voglicad 0.2mg Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglicad 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Valiolamine analog |
| Developing Habits | No. |
| Type of Therapy | Diabetes Medication |
| Behavioral Class | Alpha-glucosidase inhibitors |
3,018 People bought this recently